Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,119.54
    +40.68 (+0.50%)
     

  • Bitcoin USD

    63,824.61
    +660.52 (+1.05%)
     

  • CMC Crypto 200

    1,380.89
    -15.65 (-1.12%)
     

  • S&P 500

    5,075.10
    +26.68 (+0.53%)
     

  • Dow

    38,108.39
    +22.59 (+0.06%)
     

  • Nasdaq

    15,779.51
    +167.75 (+1.07%)
     

  • Gold

    2,357.40
    +14.90 (+0.64%)
     

  • Crude Oil

    84.26
    +0.69 (+0.83%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Why Shares of Amyris Are Getting Crushed Today

Scott Levine, The Motley Fool
·2-min read
Why Shares of Amyris Are Getting Crushed Today

Failing to deliver on both the top and bottom lines, synthetic-biology specialist Amyris (NASDAQ: AMRS) reported disappointing third-quarter 2021 earnings results yesterday after the market closed. In addition, investors are selling shares after learning that the company is raising capital through the issuance of senior convertible notes. Although the company reported a year-over-year sales increase of 39.7%, it didn't seem to be enough to satisfy investors' appetites.

Continue reading